Rationale: Although the phosphodiesterase type 5 inhibitors sildenafil and tadalafil have
demonstrated efficacy in patients with pulmonary arterial hypertension (PAH), monotherapy …

Background Adipose-derived stem cells (ADSCs) are capable of differentiating into
cardiomyogenic and endothelial cells in vitro. We tested the hypothesis that transplantation …

Tetrandrine (Tet), the main active constituent of Stephania tetrandra root, has been
demonstrated to alleviate adjuvant-induced arthritis in rats. The present study was designed …

Background Transcatheter closure of coronary artery fistulae (CAF) has emerged as an
alternative to surgery, but there are no long‐term outcome results. Objective We report …

Catalyst doping has been widely employed as an effective method for improving the H-
exchange kinetics of complex hydrides. However, a viable hydrogen storage material …

Background: We investigated the acute vasodilator effects of iv fasudil, a specific Rho-kinase
inhibitor, on pulmonary circulation in patients with congenital heart defects (CHD) and …

BACKGROUND: Ruptured sinus of Valsalva aneurysm (RSVA) can be associated with
ventricular septal defects or isolated lesions. Percutaneous transcatheter closure of RSVA …

Background—No method is available to predict whether patients with patent ductus
arteriosus (PDA) and severe pulmonary arterial hypertension (PAH) will show persistent …

Aims: To assess the immediate and long-term outcomes of transcatheter closure of
ventricular septal defect (VSD) in combination with percutaneous coronary intervention (PCI) …

Background: It has been demonstrated that sildenafil is effective in patients with pulmonary
arterial hypertension (PAH). However, the impact of sildenafil on PAH in adults with …